O&G Vivas · Intrapartum care — medical comorbidity
Intrapartum care with existing medical conditions — structured oral station (12 minutes)
FRANZCOG oral-format station on intrapartum care with existing medical conditions: candidate defends the cardiac intrapartum plan (mWHO III, assisted second stage, no ergometrine), the diabetes glucose approach and postpartum insulin adjustment, the anticoagulation-to-neuraxial clock, and the management of a seizure in labour. Scored against the eight published RANZCOG oral domains.
On this page & tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; communication skills. This station rewards the registrar who can switch condition without losing structure. [4]
Reveal the examiner script and model responses
Opening prompt — "Walk me through how you would manage her labour."
Model response — start with the plan, then the specifics: [4]
- "First I would find and read her written intrapartum plan, agreed antenatally by obstetrics, cardiology and anaesthesia. The whole of safe care for a class III lesion depends on that plan being in the notes and followed."
- "She is mWHO class III — severe aortic stenosis is a fixed-output lesion. The default is planned vaginal birth in a centre with cardiology and intensive care, because ROPAC found planned caesarean was not beneficial for most cardiac women."[5][4]
- "My plan: left lateral position, continuous pulse oximetry and strict fluid balance, an early slow epidural to blunt the catecholamine surge, an assisted second stage to shorten bearing down, and oxytocin slow and dilute for the third stage — never ergometrine, because it causes an acute afterload rise and can precipitate pulmonary oedema."[4]
Probe 1 — "Why avoid ergometrine, and what do you use instead?"
- "Ergometrine causes acute systemic vasoconstriction. In a fixed-output lesion that cannot raise its cardiac output, the afterload rise backs up into the lungs and causes pulmonary oedema. It is contraindicated in cardiac disease and hypertension."
- "Instead I use oxytocin for the third stage, given slowly and dilute — a rapid bolus also causes hypotension and tachycardia, which she will not tolerate. I would have a low threshold for an actively managed third stage given her risk."[4]
Probe 2 — "A second woman on the suite has type 1 diabetes. What is your intrapartum glucose plan?"
- "Tight capillary glucose control, monitored hourly through labour, with an insulin and dextrose infusion if it drifts. The standard target range is around 4 to 7 mmol per litre, the level achieved in the randomised comparison of intrapartum regimens. A rotating-fluids regimen is a reasonable alternative and was comparable to an insulin drip."[7]
- "The key moment is birth: insulin requirements fall off a cliff as the placental insulinase is delivered, so I halve the infusion immediately and transition her back towards her prepregnancy regimen. I would also put a neonatal hypoglycaemia alert on the baby."[6]
Probe 3 — "A third woman is on therapeutic enoxaparin for a recent PE and wants an epidural. How do you counsel her?"
- "For therapeutic-dose low-molecular-weight heparin, the ASRA guidance requires a 24-hour interval before any neuraxial procedure, and the next dose waits 4 hours after catheter removal. Prophylactic-dose is 12 hours — the difference matters."[10]
- "If she is in labour sooner than the window allows, I would discuss options with the anaesthetist — a carefully titrated approach, or a general anaesthetic if a caesarean becomes necessary. I would not compromise the window to expedite the block."
- "The reassurance is that a systematic review found no case of obstetric spinal epidural haematoma when the timing rules are kept — which is exactly why we keep them rather than assume them away."[8][10]
Probe 4 — "A fourth woman with epilepsy has a tonic-clonic seizure at 7 cm. What now?"
Say the sequence out loud, then defend the differential: [11]
- "Airway, left lateral, call for help, time the seizure. For ongoing seizure I would give intravenous lorazepam 4 mg, repeated once after 10 minutes."
- "Then I rule out eclampsia — check the blood pressure, the reflexes, the urinalysis. If eclampsia is possible I give magnesium sulphate; it is safer to treat first and clarify the diagnosis afterwards."
- "I would continue her antiseizure medication — never stop it because she is nil by mouth — and arrange one-to-one care. A seizure in labour is eclampsia until proven otherwise, but a woman with epilepsy is allowed to have epilepsy."[11]
Probe 5 — "She is anxious about what happens after the birth."
Communication is scored — demonstrate the conversation: [4]
- Move to her eye level, use her name: "You have done the hard part. We will keep a close eye on you for the next few days, because the period after birth is when the heart is under the most strain as fluid moves around."
- Explain the surveillance plan plainly: high-dependency for 72 hours, daily review, and a clear point of contact. Reassure about breastfeeding where the lesion allows it.
- Commit to a debrief and to pre-pregnancy counselling with her cardiologist before she thinks about another pregnancy.[4]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References7Show ledgerHide ledger
- [4]Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J, 2018.PMID 30165544
- [5]Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart, 2015.PMID 25539946
- [6]Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet, 2017.PMID 28923465
- [7]Rosenberg VA, Eglinton GS, Rauch ER, Skupski DW Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol, 2006.PMID 16893507
- [8]Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv, 2018.PMID 30482767
- [10]Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med, 2018.PMID 29561531
- [11]Harden CL, Hopp J, Ting TY, Pennell PB, French JA, Allen Hauser W, Wiebe S, Gronseth GS, Thurman D, Meador KJ, Koppel BS Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 2009.PMID 19496807